These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 32353823)
1. The effect of Berberine on weight loss in order to prevent obesity: A systematic review. Ilyas Z; Perna S; Al-Thawadi S; Alalwan TA; Riva A; Petrangolini G; Gasparri C; Infantino V; Peroni G; Rondanelli M Biomed Pharmacother; 2020 Jul; 127():110137. PubMed ID: 32353823 [TBL] [Abstract][Full Text] [Related]
2. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats. Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077 [TBL] [Abstract][Full Text] [Related]
3. Berberine Modulates Gut Microbiota and Reduces Insulin Resistance via the TLR4 Signaling Pathway. Liu D; Zhang Y; Liu Y; Hou L; Li S; Tian H; Zhao T Exp Clin Endocrinol Diabetes; 2018 Sep; 126(8):513-520. PubMed ID: 29365334 [TBL] [Abstract][Full Text] [Related]
4. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. Yue SJ; Liu J; Wang AT; Meng XT; Yang ZR; Peng C; Guan HS; Wang CY; Yan D Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E73-E85. PubMed ID: 30422704 [TBL] [Abstract][Full Text] [Related]
5. Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3. Zhang B; Pan Y; Xu L; Tang D; Dorfman RG; Zhou Q; Yin Y; Li Y; Zhou L; Zhao S; Zou X; Wang L; Zhang M Endocrine; 2018 Dec; 62(3):576-587. PubMed ID: 30117113 [TBL] [Abstract][Full Text] [Related]
6. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947 [TBL] [Abstract][Full Text] [Related]
7. Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. Och A; Och M; Nowak R; Podgórska D; Podgórski R Molecules; 2022 Feb; 27(4):. PubMed ID: 35209140 [TBL] [Abstract][Full Text] [Related]
8. Lipid-lowering effect of berberine in human subjects and rats. Hu Y; Ehli EA; Kittelsrud J; Ronan PJ; Munger K; Downey T; Bohlen K; Callahan L; Munson V; Jahnke M; Marshall LL; Nelson K; Huizenga P; Hansen R; Soundy TJ; Davies GE Phytomedicine; 2012 Jul; 19(10):861-7. PubMed ID: 22739410 [TBL] [Abstract][Full Text] [Related]
9. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Zhang X; Zhao Y; Xu J; Xue Z; Zhang M; Pang X; Zhang X; Zhao L Sci Rep; 2015 Sep; 5():14405. PubMed ID: 26396057 [TBL] [Abstract][Full Text] [Related]
10. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway. Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261 [TBL] [Abstract][Full Text] [Related]
11. Berberine Inhibits Adipogenesis in Porcine Adipocytes via AMP-Activated Protein Kinase-Dependent and -Independent Mechanisms. Yang Y; Liu F; Lu R; Jia J Lipids; 2019 Nov; 54(11-12):667-678. PubMed ID: 31691998 [TBL] [Abstract][Full Text] [Related]
12. Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats. Sun H; Wang N; Cang Z; Zhu C; Zhao L; Nie X; Cheng J; Xia F; Zhai H; Lu Y Obes Facts; 2016; 9(6):365-378. PubMed ID: 27898425 [TBL] [Abstract][Full Text] [Related]
13. 13-Methylberberine, a berberine analogue with stronger anti-adipogenic effects on mouse 3T3-L1 cells. Chow YL; Sogame M; Sato F Sci Rep; 2016 Dec; 6():38129. PubMed ID: 27917887 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of preadipocyte differentiation and lipid accumulation by Orengedokuto treatment of 3T3-L1 cultures. Ikarashi N; Tajima M; Suzuki K; Toda T; Ito K; Ochiai W; Sugiyama K Phytother Res; 2012 Jan; 26(1):91-100. PubMed ID: 21557367 [TBL] [Abstract][Full Text] [Related]
15. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway. Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556 [TBL] [Abstract][Full Text] [Related]
16. Effects of Berberine on the Gastrointestinal Microbiota. Zhang L; Wu X; Yang R; Chen F; Liao Y; Zhu Z; Wu Z; Sun X; Wang L Front Cell Infect Microbiol; 2020; 10():588517. PubMed ID: 33680978 [TBL] [Abstract][Full Text] [Related]
17. Berberine Ameliorates Periodontal Bone Loss by Regulating Gut Microbiota. Jia X; Jia L; Mo L; Yuan S; Zheng X; He J; Chen V; Guo Q; Zheng L; Yuan Q; Xu X; Zhou X J Dent Res; 2019 Jan; 98(1):107-116. PubMed ID: 30199654 [TBL] [Abstract][Full Text] [Related]
18. Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. Xu JH; Liu XZ; Pan W; Zou DJ Mol Med Rep; 2017 May; 15(5):2765-2787. PubMed ID: 28447763 [TBL] [Abstract][Full Text] [Related]
19. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase. Wu XM; Ren T; Liu JF; Liu YJ; Yang LC; Jin X Biomed Pharmacother; 2018 Jul; 103():1384-1391. PubMed ID: 29864922 [TBL] [Abstract][Full Text] [Related]
20. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe Zhu L; Zhang D; Zhu H; Zhu J; Weng S; Dong L; Liu T; Hu Y; Shen X Atherosclerosis; 2018 Jan; 268():117-126. PubMed ID: 29202334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]